GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world’s sixth largest pharmaceutical company according to Forbes as of 2019.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of July 2021, it had a market cap of $100 Billion, the fourth largest on the London Stock Exchange. GSK has almost 100,000 employees across dozens of offices worldwide.
The pharmaceutical industry is one of the most regulated in the world, with frequent compliance audits of many aspects of its business operations. Regulated compliance audits for operating systems primarily are standard practices and compounded with HIPAA, fines for non-compliances can become significant. GSK required a migration of a wide array of business-critical windows production applications into new and compliant OS environments in order to meet regulatory standards.
GSK chose VirtaMove to perform the migration process and migrate these applications into regulatory compliant OS environments. Using VirtaMove’s migration suite of products, expertise and methodology, we were able to ensure the migration process took place quickly and efficiently without any disruptions to critical applications running on those servers.
- Ensured non-compliant OS environments were retired and removed from audit schedule
- Eliminated exposed security gaps and improved security posture
- Reduced operational cost of on-prem server maintenance
- Reduced cost of application migration
“VirtaMove facilitates fast, efficient migration of our Windows production applications onto our new environment, and we are very pleased with the results.”
Director of Hosting Solutions, GSK